Alpine Immune Sciences Inc reports results for the quarter ended in March - Earnings Summary

Alpine Immune Sciences

12/05/2022 22:39

* Alpine Immune Sciences Inc  ALPN.OQ  reported a quarterly
adjusted loss of 25 cents​​ per share for the quarter ended in
March. The mean expectation of four analysts for the quarter was
for a loss of 19 cents per share.
    * Revenue rose 325.4% to $13.63 million from a year ago; 
analysts
expected $16.26 million. 
    * The mean earnings estimate of analysts had risen by
about 23.5%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Alpine Immune Sciences Inc shares had fallen by 21.4% this
quarter and lost 49.1% so far this year.
    * The company reported a quarterly loss of $7.53 million.
    * Wall Street's median 12-month price target for Alpine
Immune
Sciences Inc is $21.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated May 12 at 09:38 p.m.  ​All
figures in US dollars unless otherwise stated